Amazon S3 on MSN
WHO supports weight loss drugs for tackling obesity crisis
Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...
A webcast of the conference call can be accessed by visiting “Investor Events” on the investor relations section of the Wave Life Sciences website: ...
GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...
Researchers found that older adults with diabetes who used semaglutide had more than twice the risk of developing a serious ...
Q: I'm 68 and overweight by 45 pounds. Now that GLP-1s are going to be covered by Medicare, I think I will add that to my regimen -- I also take a statin. Does that make sense to you?-- Steve T., ...
Serena Williams, the 23-time Grand Slam tennis champion, has taken the first step toward a potential comeback by reentering ...
Indian health-tech startup Healthify is in talks to partner with more weight-loss drugmakers to offer health, nutrition and ...
Uncover common misconceptions about GLP-1s for weight loss. Learn the importance of diet, exercise, managing side effects, ...
FTC finalizes order shutting down deceptive marketing by telemedicine firm NextMed • Company accused of hiding costs, faking ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed ...
Changing consumer habits, in some cases driven by weight loss medications, inflation, and digital convenience, are reshaping ...
A roundup of the most newsworthy healthcare press releases from PR Newswire, including new company mergers, Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results